1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Optic Pathway Glioma: new trials by email Literature Review of Optic Pathway Glioma trials Research Report on Optic Pathway Glioma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of the PAINLESS Nerve Growth Factor CHF6467 in Optic Pathway Glioma (OPG) CHF6467, Placebo - Optic Pathway Glioma | Phase 2 | Active not recruiting | Benedetto Falsini | 36 | 2023-06-12 | 2026-10-27 |
Hereditary Sensory and Autonomic Neuropathies (1) · Optic Atrophy (1)
Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Cranial Nerve Diseases (1) · Eye Diseases (1) · Genetic Diseases, Inborn (1) · Heredodegenerative Disorders, Nervous System (1) · Nervous System Diseases (1) · Nervous System Malformations (1) · Neurodegenerative Diseases (1) · Neuromuscular Diseases (1) · Optic Nerve Diseases (1) · Peripheral Nervous System Diseases (1) · Polyneuropathies (1)
Italy (1)